Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL

Trial results supported recent FDA approval for patients with relapsed/refractory disease

2024-11-27

(Press-News.org) Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene autoleucel (obe-cel), experienced high response rates and most did not need a subsequent stem cell transplant (SCT), according to results from the Phase Ib/II FELIX trial co-led by researchers at The University of Texas MD Anderson Cancer Center.

The findings, published today in the New England Journal of Medicine, showed a 76.6% response rate and 55.3% complete remission rate in 127 evaluable patients. The median event-free survival (EFS) was 11.9 months, and the EFS rates at six and 12 months were 65.4% and 49.5%, respectively. The median overall survival (OS) for infused patients was 15.6 months. At six and 12 months, the estimated OS rates were 80.3% and 61.1%, respectively.

Based on these data, the Food and Drug Administration approved obe-cel for the treatment of relapsed or refractory B-cell ALL in adult patients in Nov. 2024. Additional findings from the study will be presented Dec. 9 at the 2024 American Society of Hematology (ASH) Annual Meeting by Elias Jabbour, M.D., professor of Leukemia and the study’s U.S. lead investigator.

“Patients with B-cell ALL need effective standalone treatment options, and obe-cel demonstrated strong long-term efficacy and response rates in patients treated on the FELIX study,” Jabbour said. “Until now, these patients had limited treatment options. We observed minimal immunotoxicity and a strong persistence of CAR T cells, which support obe-cel being the standard of care for this population.”

The global, multi-center FELIX trial treated 127 adults with relapsed or refractory B-cell ALL. Prior to receiving obe-cel, trial participants had lymphodepletion – an important step to eliminate existing T cells and create a blank slate for CAR T cell therapy – followed by obe-cel infusion in split doses on days one and 10. The median age of trial participants was 47 years and 52% were male. Patients were 74% white, 12.6% Asian, 1.6% Black and 11.8% unknown.

Toxicities were mostly limited to patients with high bone marrow burden. Patients experienced a low grade of cytokine release syndrome (CRS) and neurotoxicity, which are associated with CAR T cell therapies. Three patients experienced CRS symptoms of grade 3 or higher, and nine patients experienced immune effector cell-associated neurotoxicity syndrome of grade 3 or higher. Observed side effects were consistent with previous studies, and no new adverse effects were identified.

Among the 99 patients who responded to obe-cel, only 18 went on to receive a SCT while in remission at a median of 101 days after their infusion. Researchers observed no difference in EFS and OS between patients who received a SCT and those who did not, suggesting a durable response from obe-cel therapy.

The trial also demonstrated significant clearance of minimal residual disease (MRD) following obe-cel treatment. In patients with blood cancers, MRD refers to a small number of cancer cells remaining after treatment that have the potential to cause relapse.

On the study, 68 high-risk patients – defined as those with bone marrow blasts greater than 5% prior to lymphodepletion – achieved a complete remission. In this group, 62 patients had MRD data available, and 58 patients were MRD-negative after obe-cel infusion.

In the upcoming ASH presentation, Jabbour will highlight the correlation between depth of MRD-negative remission and clinical outcomes in patients treated with obe-cel. Prior to lymphodepletion, researchers evaluated patient bone marrow samples by next generation sequencing (NGS). The findings indicate lower levels of MRD were associated with a stronger response, including higher EFS and OS rates, Jabbour explained.

The study was funded by Autolus Therapeutics. A complete list of collaborating authors and their disclosures can be found here.

END

ELSE PRESS RELEASES FROM THIS DATE:

Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention

2024-11-27

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including attending doctor’s visits every three months and – most importantly – consistency. These daily oral antiretrovirals, more commonly referred to as PrEP (pre-exposure prophylaxis), such as Truvada®, are extremely effective at HIV prevention, but only if they are taken daily as directed. Truvada’s efficacy is greatly compromised when taken inconsistently. However, results from a recent Gilead-funded clinical trial (Purpose-2) led by physicians at Emory University ...

Discovering the traits of extinct birds

2024-11-27

Looking to inform the conservation of critically endangered bird species, University of Utah biologists completed an analysis identifying traits that correlate with all 216 bird extinctions since 1500. Species most likely to go extinct sooner were endemic to islands, lacked the ability to fly, had larger bodies and sharply angled wings, and occupied ecologically specific niches, according to research published this month. While some of these findings mirror previous research on extinct birds, they are the first to correlate bird traits with the timing of ...

Are health care disparities tied to worse outcomes for kids with MS?

2024-11-27

MINNEAPOLIS – People who develop multiple sclerosis (MS) as children and grow up in less advantaged neighborhoods may have a larger volume of inflammation and brain tissue loss on imaging than those who grow up in more advantaged neighborhoods, according to a study published in the November 27, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. MS rarely develops in children. About 5% of people with MS are diagnosed before age 18. In addition to neighborhood location, worse brain imaging outcomes were also seen ...

For those with CTE, family history of mental illness tied to aggression in middle age

2024-11-27

EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, NOVEMBER 27, 2024 MINNEAPOLIS – People who have chronic traumatic encephalopathy (CTE) who have a family history of mental illness may have a higher risk of aggression in middle age, according to a study published in the November 27, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. CTE is a neurodegenerative disease associated with repeated head injuries, often seen in athletes and military personnel, that can lead to mood changes and dementia. “This ...

The sound of traffic increases stress and anxiety

2024-11-27

Manmade sounds such vehicle traffic can mask the positive impact of nature soundscapes on people’s stress and anxiety, according to a new study published November 27, 2024, in the open-access journal PLOS ONE by Paul Lintott of the University of the West of England, U.K., and Lia Gilmour of the Bat Conservation Trust, U.K. Existing research shows that natural sounds, like birdsong, can lower blood pressure, heart, and respiratory rates, as well as self-reported stress and anxiety. Conversely, anthropogenic soundscapes, like traffic or aircraft noise, are hypothesized to have negative effects on human health and wellbeing in a variety ...

Global food yields have grown steadily during last six decades

2024-11-27

Contrary to widespread concerns that global crop yields have stagnated in recent decades, a comprehensive study of worldwide food production finds yields have continued to grow at roughly the same rate since the 1960s. John Baffes of the World Bank and Xiaoli Etienne of the University of Idaho, U.S., report these findings on November 27, 2024, in the open-access journal PLOS ONE. Almost 10 billion people are expected to inhabit Earth by 2050, so agricultural production will become increasingly critical ...

Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study

2024-11-27

Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study ### Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0313078 Article Title: Gut microbiota markers in early childhood are linked to farm living, pets in household and allergy Author Countries: Sweden Funding: This work was supported by the Region Västra Götaland (agreement concerning medical research and education – ALF), https://www.alfvastragotaland.se [ALFGBG966243] [ALFGBG720181] ...

North American Early Paleoindians almost 13,000 years ago used the bones of canids, felids, and hares to create needles in modern-day Wyoming, potentially to make the tailored fur garments which enabl

2024-11-27

North American Early Paleoindians almost 13,000 years ago used the bones of canids, felids, and hares to create needles in modern-day Wyoming, potentially to make the tailored fur garments which enabled their dispersal into these colder climates ### Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0313610 Article Title: Early Paleoindian use of canids, felids, and hares for bone needle production at the La Prele site, Wyoming, USA Contact: Spencer Pelton, spencer.pelton@wyo.gov, Ph. +1 307 399 2827 Author Countries: U.S. Funding: Funding for this project includes the National Science Foundation (award #1947297), the ...

Higher levels of democracy and lower levels of corruption are associated with more doctors, independent of healthcare spending, per cross-sectional study of 134 countries

2024-11-27

Higher levels of democracy and lower levels of corruption are associated with more doctors, independent of healthcare spending, per cross-sectional study of 134 countries. ### Article URL: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal. pgph.0003656 Article Title: The relationship between democracy and corruption and the global physician workforce Author Countries: Canada Funding: The authors received no specific funding for this work. END ...

In major materials breakthrough, UVA team solves a nearly 200-year-old challenge in polymers

2024-11-27

Researchers at the University of Virginia School of Engineering and Applied Science have developed a new polymer design that appears to rewrite the textbook on polymer engineering. No longer is it dogma that the stiffer a polymeric material is, the less stretchable it has to be. “We are addressing a fundamental challenge that has been thought to be impossible to solve since the invention of vulcanized rubber in 1839,” said Liheng Cai, an assistant professor of materials science and engineering, and chemical engineering. That’s when Charles Goodyear accidentally discovered that heating natural rubber with sulfur ...

LAST 30 PRESS RELEASES:

Survey of 12 European countries reveals the best and worst for smoke-free homes

First new treatment for asthma attacks in 50 years

Certain HRT tablets linked to increased heart disease and blood clot risk

Talking therapy and rehabilitation probably improve long covid symptoms, but effects modest

Ban medical research with links to the fossil fuel industry, say experts

Different menopausal hormone treatments pose different risks